Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma. [electronic resource]
Producer: 20111102Description: 1447-60 p. digitalISSN:- 1432-0851
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- therapy
- Cell Separation
- Diphosphonates -- therapeutic use
- Female
- Flow Cytometry
- Humans
- Imidazoles -- therapeutic use
- Immunotherapy -- methods
- Interleukin-2 -- therapeutic use
- Kidney Neoplasms -- therapy
- Lymphocyte Activation -- drug effects
- Male
- Middle Aged
- Pilot Projects
- Receptors, Antigen, T-Cell, gamma-delta -- immunology
- T-Lymphocytes -- immunology
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.